stella
beta
Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer — Stella
Home
/
Non-muscle Invasive Bladder Cancer (NMIBC)
/
Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer
View on ClinicalTrials.gov
Recruiting
Back to Non-muscle Invasive Bladder Cancer (NMIBC) trials
Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
United States
Lahey Hospital and Medical Center, Burlington, Massachusetts